دورية أكاديمية

Real-World Outcomes of Ribociclib and Aromatase Inhibitor Use in First Line Hormone Receptor Positive, HER2-Negative Metastatic Breast Cancer

التفاصيل البيبلوغرافية
العنوان: Real-World Outcomes of Ribociclib and Aromatase Inhibitor Use in First Line Hormone Receptor Positive, HER2-Negative Metastatic Breast Cancer
المؤلفون: Wong, Vanessa, de Boer, Richard, Baron-Hay, Sally, Blum, Robert, Boyle, Frances, Chua, Susan, Clarke, Kerrie, Cuff, Katharine, Green, Michael, Lim, Elgene, Mok, Kelly, Nott, Louise, Nottage, Michelle, Tafreshi, Ali, Tsoi, Daphne, Uccellini, Anthony, Hong, Wei, Gibbs, Peter, Lok, Sheau Wen
المصدر: In Clinical Breast Cancer December 2022 22(8):792-800
قاعدة البيانات: ScienceDirect
الوصف
تدمد:15268209
DOI:10.1016/j.clbc.2022.08.011